German pharmaceutical firm BioNTech, one of the first companies worldwide to develop an effective coronavirus vaccine, is looking to acquire its domestic rival CureVac, the firm said on Thursday.

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in the first-in-human clinical trial to ...

The manipulated video of Tiangco reporting on the alleged anti-aging serum was posted by a fake Facebook page posing as ...

Louisiana Attorney General Liz Murrill plans to send a cease and desist letter to CVS for mass text messages sent to ...

Model post-training and inference will run on AI infrastructure in Europe from NVIDIA Cloud Partners ( NCPs) participating in ...

Corbus Pharmaceuticals Holdings Inc. closed 85.74% short of its 52-week high of $61.90, which the company reached on July ...

This was the stock's third consecutive day of losses.

Given that the Australian government heavily subsidizes pharmaceuticals— spending more than $AU16.7 billion annually through ...

Optimize your leadership role in the competitive pharmaceutical industry with the Pharma Mini MBA. This accelerated, three-day course blends practical management tools with industry-specific case ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

The pharmaceutical grade sodium chloride market is set to grow from USD 701.9 million in 2024 to USD 973.7 million by 2030, ...